A hypothesis for the impact of the Val141Leu SNP on the survival rate might be an altered modulation of patients’ immune systems [109], as it was recently suggested that IRAG2 might act as a tumor suppressor that is involved in the progression of lung adenocarcinoma (s. The gene discussed is IRAG2; the disease is neoplasm.